Changes in retinal venous diameter in proliferative diabetic retinopathy patients with diabetic macular edema following faricimab treatment: an observational study - Takeaways - MDSpire

Changes in retinal venous diameter in proliferative diabetic retinopathy patients with diabetic macular edema following faricimab treatment: an observational study

  • By

  • Hui Zhao

  • Yuanqing Liu

  • Lingchao Zhang

  • Xiaonan Zhao

  • Nan Wang

  • Yuan Tao

  • Hong Wang

  • July 9, 2026

  • 0 min

Share

  • 1

    The study evaluated the effects of intravitreal faricimab on retinal venous diameter in PDR patients with DME.

  • 2

    A total of 46 PDR patients received faricimab and panretinal photocoagulation between August 2024 and January 2025.

  • 3

    Significant improvements in best-corrected visual acuity and reductions in central foveal thickness were observed at all follow-up time points.

  • 4

    Retinal venous diameter showed no significant change at 1 and 3 months but was significantly reduced at 6 months post-treatment.

  • 5

    The study concluded that faricimab may influence retinal microvascular remodeling through dual inhibition of VEGF-A and Ang-2.

Original Source(s)

Changes in retinal venous diameter in proliferative diabetic retinopathy patients with diabetic macular edema following faricimab treatment: an observational study

  • by Hui Zhao, Yuanqing Liu, Lingchao Zhang, Xiaonan Zhao, Nan Wang, Yuan Tao, Hong Wang

  • July 9, 2026

Related Content

Benchmark for Functional Vision Loss Uncovered in Older Adults

A nationally representative US cohort identified a contrast sensitivity threshold associated with self-reported visual disability.

FDA Alignment Boosts Wet AMD Treatment Path

Ocular Therapeutix plans Q4 NDA filing for AXPAXLI

  • July 7, 2026

  • 3 min
Longitudinal changes in anatomic biomarkers on optical coherence tomography angiography in diabetic retinopathy